Hematology/Oncology

• Meeting News Coverage

• Advances enacted in the regulation of sunscreen and tanning beds

• April 2, 2013
• NEW YORK — Advances in regulations in tanning beds and sunscreens include limiting minors in their use of indoor tanning and FDA approval for new...More »

• Meeting News Coverage

• Advances enacted in the regulation of sunscreen and tanning beds

• HemOnc Today, May 10, 2013
• NEW YORK — Advances in regulations in tanning beds and sunscreens include limiting minors in their use of indoor tanning and FDA approval for new...More »

• Meeting News Coverage

• Emerging technologies allow patients, computers to help diagnose melanoma

• April 1, 2013
• NEW YORK — Emerging technologies during the next 5 to 10 years will assist physicians in surveillance of melanoma through advances in imaging, as...More »

• Meeting News Coverage

• Emerging technologies allow patients, computers to help diagnose melanoma

• HemOnc Today, May 10, 2013
• NEW YORK — Emerging technologies during the next 5 to 10 years will assist physicians in surveillance of melanoma through advances in imaging, as...More »

• Clinician receives professorship

• HemOnc Today, April 25, 2013
• Takami Sato
  
  Takami Sato, MD, PhD, director of the metastatic uveal melanoma program at Thomas Jefferson University, has been named the first K. Hasumi...More »

• Highlights from the HemOnc Today Melanoma meeting

• April 1, 2013
• NEW YORK - Sanjiv S. Agarwala, MD, highlights the topics covered at the HemOnc Today Melanoma symposium including surgical treatments, therapy, metastatic ......More »

• IL2 Single Agent and Combinations

• March 29, 2013
• Michael K.K. Wong, MD, PhD, FRCPC, discussed IL-2 being a viable first option in selected patients with metastatic melanoma and that it is a viable ......More »

• PD1 Antibodies

• March 29, 2013
• Jeffrey Weber, MD, PhD, explained PD-1's role in T cell activation at the HemOnc Today Melanoma and Cutaneous Malignancies symposium. Weber explained that ......More »

• Adoptive TCell Transfer

• March 29, 2013
• Patrick Hwu, MD, discussed recent results of an ongoing adoptive cell therapy trial, MDACC TIL ACT clinical trial, at the HemOnc Today Melanoma and ......More »

• Meeting News Coverage Perspective

• Nab-paclitaxel shows promise in treatment of metastatic melanoma

• March 28, 2013
• NEW YORK — Nanoparticle albumin-bound paclitaxel is an active agent in the treatment of malignant melanoma, but its role in relationship to targeted...More »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!